source
- Eli Lilly's claims data deadline may kick off new 340B fightEli Lilly’s deadline has passed for hospitals to comply with its new 340B claims data policy, and for now the pharma company is staying mum on its next steps. But just because Lilly is declining ...Endpoints · 1mo ago↗ source
- Grace Science says FDA bottleneck jeopardizes rare disease therapyGrace Science appeared to be one of the few companies fighting ultra-rare diseases whose gene therapy candidate might make it across the finish line. Co-founded by Nobel laureate Carolyn Bertozzi,…Endpoints · 1mo ago↗ source
- A different approach to lowering healthcare costsLast month, Garner Health raised $100 million, vaulting its valuation to $2.7 billion. At first, this startup sounded more like a doctor-rankings company, which I’d typically think of as more ...